– Advertisement –
Copenhagen-based Liva Healthcare has acquired UK-based Discover Momenta and Momenta Newcastle for an undisclosed sum, expanding its role in delivering evidence-based lifestyle intervention programmes. Both companies provide therapeutic support for chronic conditions such as obesity and Type 2 diabetes, with Momenta’s programmes widely used by NHS organisations and local authorities. The acquisition is accompanied by new funding from Danish investor IBL Group, through Nupo, alongside existing investors MIG Capital, Santo Venture Capital, Maj Invest, and other private investors. The move reflects broader industry trends towards digital and hybrid healthcare solutions, integrating behavioural health expertise with scalable technology to address rising rates of chronic disease.
Liva Healthcare develops and delivers therapeutic lifestyle intervention programmes for chronic conditions such as obesity, Type 2 diabetes, and cardiovascular diseases. The company provides a combination of digital tools and human-led coaching to support long-term behavioural changes. Liva works with healthcare providers, insurers, and public health organizations, including the NHS, to offer scalable intervention solutions.
Momenta designs and delivers structured lifestyle intervention programmes focused on weight management and chronic disease prevention. Its programmes, which are available in digital, virtual, and in-person formats, are used by NHS organizations, local authorities, and healthcare providers. Momenta applies behavioural science principles to support long-term health improvements and address public health challenges.
The purchase of Momenta comes as Liva has secured additional funding to accelerate its growth plans. The fundraising was led by a new investor, IBL Group, a Danish family-owned investment company, through its portfolio company Nupo, with participation from existing investors MIG, Santos, MajInvest and other private investors.
“Today’s news marks a step-change in Liva’s ambitions, as we embark on a revamped strategic growth plan to help more people prevent, manage and reverse their chronic conditions. Momenta is a highly regarded supplier of evidence-based healthy lifestyle programmes, and this acquisition cements Liva’s position as one of the largest providers of such services to the NHS in England. The purchase has been enabled by the investment from IBL Group / Nupo, who we are delighted to welcome as a new investor,” Shahram Sharif, CEO of Liva Healthcare, said. “Liva has been growing rapidly over the last few years and has now enabled over 80,000 patients to better manage or even reverse their chronic conditions. These developments put the Company on the front foot as we seek to become the go-to provider of these evidence-based disease management programmes in Europe and beyond.”
Harry MacMillan, CEO of Momenta, who joins the leadership team of Liva Healthcare, said: “Momenta and Liva share the same vision, and I am delighted we are joining forces. Our combined track records in programme and platform development and digital, virtual and in-person delivery are highly complementary. Liva’s digital platform will enable many more people across the UK and beyond to benefit from Momenta’s expert-developed chronic disease management programmes. This scalability is essential to stem the rising tide of chronic conditions such as obesity, Type 2 diabetes, and cardiovascular disease in a meaningful and cost-effective way.”
Peter Wedelheim, CEO of Nupo, which is backed by IBL Group, said: “The combination of advanced digital technology, including AI, with personalised coaching means that Liva is perfectly positioned to help the growing numbers of people around the world who are suffering from these lifestyle-related chronic conditions. We are excited to be working with them to bring the benefits of this approach to the many patients who can benefit.”
Click to read more funding news.
Click here to read more IPO/M&A news.
– Advertisement –
